These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3537837)

  • 1. Cholinergic function and intellectual decline in Alzheimer's disease.
    Collerton D
    Neuroscience; 1986 Sep; 19(1):1-28. PubMed ID: 3537837
    [No Abstract]   [Full Text] [Related]  

  • 2. The cholinergic hypothesis: a historical overview, current perspective, and future directions.
    Bartus RT; Dean RL; Pontecorvo MJ; Flicker C
    Ann N Y Acad Sci; 1985; 444():332-58. PubMed ID: 2990293
    [No Abstract]   [Full Text] [Related]  

  • 3. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
    Candy JM; Perry EK; Perry RH; Court JA; Oakley AE; Edwardson JA
    Prog Brain Res; 1986; 70():105-32. PubMed ID: 3554348
    [No Abstract]   [Full Text] [Related]  

  • 4. Dementia in the elderly: biochemical aspects.
    Bowen DM; Davison AN
    J R Coll Physicians Lond; 1984 Jan; 18(1):25-7. PubMed ID: 6142949
    [No Abstract]   [Full Text] [Related]  

  • 5. The functional organization of the basal forebrain cholinergic system in primates and the role of this system in Alzheimer's disease.
    Price DL; Cork LC; Struble RG; Whitehouse PJ; Kitt CA; Walker LC
    Ann N Y Acad Sci; 1985; 444():287-95. PubMed ID: 3160283
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathophysiology of senile dementia].
    Karobath M
    Schweiz Med Wochenschr; 1985 Dec; 115(50):1803-7. PubMed ID: 2868521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease.
    Bajalan AA; Wright CE; van der Vliet VJ
    J Neurol Neurosurg Psychiatry; 1986 Feb; 49(2):175-82. PubMed ID: 3950635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic markers in the early diagnosis of Alzheimer's disease.
    Jenden DJ
    Bull Clin Neurosci; 1985; 50():49-52. PubMed ID: 3915951
    [No Abstract]   [Full Text] [Related]  

  • 9. Is the loss of cerebral cortical choline acetyl transferase activity in Alzheimer's disease due to degeneration of ascending cholinergic nerve cells.
    Mann DM; Yates PO
    J Neurol Neurosurg Psychiatry; 1982 Oct; 45(10):936. PubMed ID: 7143014
    [No Abstract]   [Full Text] [Related]  

  • 10. The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo.
    Scali C; Giovannini MG; Prosperi C; Bellucci A; Pepeu G; Casamenti F
    Neuroscience; 2003; 117(4):909-19. PubMed ID: 12654342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical review of the role of the cholinergic system in human memory and cognition.
    Davies P
    Ann N Y Acad Sci; 1985; 444():212-7. PubMed ID: 3860088
    [No Abstract]   [Full Text] [Related]  

  • 12. Alzheimer's disease: a disorder of cortical cholinergic innervation.
    Coyle JT; Price DL; DeLong MR
    Science; 1983 Mar; 219(4589):1184-90. PubMed ID: 6338589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
    Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
    J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cholinergic system and the excitatory amino acids in Alzheimer's disease.
    Bowen D
    Acta Neurol Scand Suppl; 1990; 129():15-6. PubMed ID: 2220318
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathophysiology of dementia.
    Plum F
    Gerontology; 1986; 32 Suppl 1():67-72. PubMed ID: 3732820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 17. Pro- and anti-apoptotic evidence for cholinergic denervation and hippocampal sympathetic ingrowth in rat dorsal hippocampus.
    Harrell LE; Parsons DS; Kolasa K
    Exp Neurol; 2005 Jul; 194(1):182-90. PubMed ID: 15899255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain mechanisms in Alzheimer's disease.
    Coyle JT; Price DL; DeLong MR
    Hosp Pract (Off Ed); 1982 Nov; 17(11):55-63. PubMed ID: 6127308
    [No Abstract]   [Full Text] [Related]  

  • 19. Dementia without cholinergic deficit.
    Riekkinen PJ; Soininen H; Sirviö J; Reinikainen K; Helkala EL; Paljärvi L
    Gerontology; 1987; 33(3-4):268-72. PubMed ID: 3653707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ
    J Clin Psychiatry; 1998; 59 Suppl 13():19-22. PubMed ID: 9771826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.